Oct. 19, 2012 (China Knowledge) - Harbin Pharm Group Sanjing Pharmaceutical Co Ltd<600829
>, which is based in Harbin
, the capital of Heilongjiang
Province, has said its net profit for the first nine months of this year plunge 27.71% YoY to RMB 230 million.
The company said the loss in profit was mainly affected by the country's pharmaceutical industry environment and the medicine industry policy.
According to a statement, basic earnings per share for the nine-month period were RMB 0.4.
From January to September 2012, the Shanghai listed
company saw its operation revenue grow 11.51% YoY to RMB 3.01 billion, including RMB 908 million from Q3, up 1.11% from a year earlier.